Next-Generation Sequencing
In a new study, Dana Farber researchers and collaborators explain the myriad molecular reasons why KRAS-mutated cancers develop resistance to targeted therapy.
Genomic Testing Cooperative's Hematologic Neoplasms, Solid Tumor Tests Receive NY State Approval, Medicare Coverage
The next-generation sequencing-based tests can be performed on small samples, including needle aspiration samples, and use artificial intelligence software.
BostonGene Looks to Bolster Immunotherapy Response Prediction With Tumor Microenvironment Subtypes
Premium
The company's analytics platform identified four tumor microenvironment subtypes that can segment 20 cancer types according to prognosis and therapeutic response.
Molecular Profiling in Pediatric Cancer Trials Continues to Prove Valuable for Treatment Matching
Premium
The GAIN/iCat2 study and the Pediatric MATCH trial showed that molecular data has a significant impact on treatment recommendations for kids with cancer.
Hummingbird Bioscience, Novogene Partner to ID Cancer Patients With NRG1 Fusions in China
Novogene will use next-generation sequencing to identify solid tumor patients eligible to enroll in clinical trials of Hummingbird's anti-HER3 agent, HMBD-001.